Shopping Cart
- Remove All
- Your shopping cart is currently empty
VK-0214 is an agonist of thyroid receptor β (TRβ) that improves X-linked adrenoleukodystrophy (X-ALD) by activating ABCD2 expression and reducing the accumulation of very long-chain fatty acids (VLCFA).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | VK-0214 is an agonist of thyroid receptor β (TRβ) that improves X-linked adrenoleukodystrophy (X-ALD) by activating ABCD2 expression and reducing the accumulation of very long-chain fatty acids (VLCFA). |
Molecular Weight | 412.42 |
Formula | C23H25O5P |
Cas No. | 852949-30-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.